Marksans Pharma Limited has published a newspaper advertisement in Business Standard and Lakshadeep on July 30, 2026, announcing the schedule for its 34th Annual General Meeting (AGM). The meeting is set for Thursday, August 27, 2026, at 11:00 a.m. and will be conducted exclusively through Video Conferencing (VC) or Other Audio Visual Means (OAVM), in compliance with Ministry of Corporate Affairs (MCA) circulars. This disclosure ensures shareholders are aware of the procedural timeline and access mechanisms for the upcoming governance event.

The filing was made pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Harshavardhan Panigrahi, Company Secretary, signed the communication on behalf of the Board. The notice confirms that the AGM will not have a physical venue for shareholder attendance, aligning with ongoing regulatory permissions for remote meetings.

Key Meeting Details

Shareholders holding shares in physical form are requested to register their email addresses and bank account details with the Registrar and Share Transfer Agent, M/s Bigshare Services Private Limited, or via the company’s website. Those holding shares in dematerialized form must update their details with their respective Depository Participants. These steps are critical for receiving the AGM notice electronically and for the payment of dividends, which are now mandated to be paid only in electronic mode to KYC-compliant folios.

What the Numbers Show

While this filing is procedural, it highlights Marksans Pharma’s adherence to digital governance standards. The exclusive use of VC/OAVM reflects the broader shift in Indian corporate governance towards remote accessibility. Shareholders must act promptly to update their KYC and bank mandates to avoid missing dividend entitlements or voting rights. The absence of physical presence requirements reduces logistical overhead but places the onus on investors to maintain accurate digital records with their depositories or RTAs.

Marksans Pharma Ltd has completed the acquisition of 100% share capital of Germany-based ABCNow GmbH. The company finalized the transaction on July 20, 2026, expanding its international footprint through this strategic move.

The acquisition was disclosed to the stock exchanges under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory filing confirms that the process to acquire the entire share capital of the German entity has been concluded.

Acquisition Details

The following table summarises the key details of the completed transaction:

The completion of this acquisition marks a significant development for Marksans Pharma as it integrates the new subsidiary into its operations. The company had initially intimated the exchanges about the proposed acquisition on July 8, 2026.